Surgery Partners, Inc.
SGRYNasdaqCIK 1638833HealthcareFiscal year ends Dec 31
Reports and events: 213 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2609:27 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-431228 |
| 2026-10-2609:03 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-118643 |
| 2026-09-1709:03 ET | 8-K | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001638833-26-000085 |
| 2026-08-1016:14 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001638833-26-000077 |
| 2026-08-1007:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001638833-26-000074 |
| 2026-07-2409:01 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001638833-26-000069 |
| 2026-06-0516:50 ET | 8-K | 5.07 Shareholder vote results | 0001638833-26-000050 |
| 2026-05-0516:13 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001638833-26-000046 |
| 2026-05-0507:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001638833-26-000044 |
| 2026-04-2316:03 ET | DEF 14A | Proxy statementPeriod 2026-06-05 | 0001638833-26-000039 |
| 2026-03-0217:11 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001638833-26-000008 |
| 2026-03-0216:55 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001638833-26-000006 |
| 2025-12-1616:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-25-121563 |
| 2025-12-1218:51 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-120386 |
| 2025-12-1108:36 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-120159 |
| 2025-11-1217:24 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001638833-25-000166 |
| 2025-11-1016:05 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001638833-25-000163 |
| 2025-11-1007:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001638833-25-000159 |
| 2025-09-1616:04 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001638833-25-000153 |
| 2025-08-1317:18 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-25-077656 |
| 2025-08-0617:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001638833-25-000138 |
| 2025-08-0516:28 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001638833-25-000136 |
| 2025-08-0507:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001638833-25-000132 |
| 2025-06-1708:34 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-087071 |
| 2025-06-1708:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001638833-25-000117 |
| 2025-06-0617:23 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001638833-25-000096 |
| 2025-05-1216:25 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001638833-25-000092 |
| 2025-05-1207:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001638833-25-000089 |
| 2025-04-2416:15 ET | DEF 14A | Proxy statementPeriod 2025-06-06 | 0001638833-25-000084 |
| 2025-03-0721:32 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001638833-25-000053 |
| 2025-03-0307:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001638833-25-000031 |
| 2025-01-2815:22 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-006658 |
| 2025-01-2808:49 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-009488 |
| 2025-01-1317:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001638833-25-000002 |
| 2024-11-1216:18 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001638833-24-000147 |
| 2024-11-1207:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001638833-24-000143 |
| 2024-08-2316:18 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001638833-24-000137 |
| 2024-08-0616:04 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001638833-24-000135 |
| 2024-08-0607:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001638833-24-000132 |
| 2024-06-2016:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-24-073419 |
| 2024-06-1117:13 ET | 8-K | 5.07 Shareholder vote results | 0001638833-24-000127 |
| 2024-05-0716:03 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001638833-24-000113 |
| 2024-05-0707:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001638833-24-000110 |
| 2024-04-2517:01 ET | DEF 14A | Proxy statementPeriod 2024-06-06 | 0001638833-24-000106 |
| 2024-04-1016:49 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-24-045863 |
| 2024-03-2615:55 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001638833-24-000081 |
| 2024-03-2608:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001638833-24-000079 |
| 2024-02-2616:45 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001638833-24-000029 |
| 2024-02-2607:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001638833-24-000026 |
| 2024-01-0807:31 ET | 8-K | 2.02 Results of operations | 0001638833-24-000006 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 04:34 ET. Listed shows no prices and gives no investment advice.